Literature DB >> 19931237

Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients.

Satoshi Hirayama1, Satoshi Soda, Yasuki Ito, Hiroshi Matsui, Tsuyoshi Ueno, Yoshifumi Fukushima, Hirotoshi Ohmura, Osamu Hanyu, Yoshifusa Aizawa, Takashi Miida.   

Abstract

BACKGROUND: Type 2 diabetic patients have a higher risk of atherosclerosis than non-diabetic subjects. This difference may be attributable to increased levels of small dense low-density lipoprotein-cholesterol (sLDL-C) in diabetic patients. As the sLDL-C concentration is elevated in hypertriglyceridemia, which is exaggerated postprandially, we examined whether the sLDL-C level increases postprandially in type 2 diabetes.
METHODS: We obtained 7 blood samples (30min before and 2h after each meal, and at midnight) from 15 patients with diabetes and ten normal controls. Following the precipitation of very low-density lipoprotein and large buoyant LDL (bLDL) with heparin-Mg(2+), the sLDL-C concentration was determined as the cholesterol concentration by a homogeneous assay.
RESULTS: The fasting sLDL-C concentration was 60.3% higher in the diabetic patients than in the controls (1.01+/-0.21 vs. 0.63+/-0.21mmol/l, p<0.001). The sLDL-C concentrations in both groups were highest in the fasting state, decreased after breakfast, and remained low until midnight. The maximal reduction in the absolute sLDL-C concentration was 56.5% greater in the diabetic patients than in the controls (0.36+/-0.13 vs. 0.23+/-0.16mmol/l, p<0.05). Thus, the sLDL-C/bLDL-cholesterol (bLDL-C) ratio was reduced with increases in bLDL-C.
CONCLUSIONS: The sLDL-C concentration decreases postprandially in diabetes. This absolute reduction in sLDL-C may contribute to an acceleration of atherosclerosis in diabetic patients. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931237     DOI: 10.1016/j.cca.2009.11.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.

Authors:  John J Albers; April Slee; Jerome L Fleg; Kevin D O'Brien; Santica M Marcovina
Journal:  Atherosclerosis       Date:  2016-06-11       Impact factor: 5.162

2.  Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Dmitry Rasskazov; Valentin Suslov; Ekaterina Sharypova; Ludmila Savinkova; Olga Podkolodnaya; Nikolay L Podkolodny; Natalya N Tverdokhleb; Irina Chadaeva; Mikhail Ponomarenko; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2016-08-22       Impact factor: 3.411

3.  Correlation between of small dense low-density lipoprotein cholesterol with acute cerebral infarction and carotid atherosclerotic plaque stability.

Authors:  Xue QiaoZhen; Meng AiGuo; Wang Tong; Li JingJing; Liu HaiYing
Journal:  J Clin Lab Anal       Date:  2019-04-06       Impact factor: 2.352

4.  Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Irina Chadaeva; Ekaterina Sharypova; Irina Drachkova; Dmitry Oshchepkov; Petr Ponomarenko; Ludmila Savinkova; Evgeniya Oshchepkova; Maria Nazarenko; Nikolay Kolchanov
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

5.  Small Dense Low-Density Lipoprotein for Risk Prediction of Acute Coronary Syndrome.

Authors:  Abhishek Singh; Rajendra Puhan; Akshyaya Pradhan; Wahid Ali; Rishi Sethi
Journal:  Cardiol Res       Date:  2021-07-09

6.  Fasting remnant lipoproteins can predict postprandial hyperlipidemia.

Authors:  Tomoki Nagata; Daisuke Sugiyama; Takako Kise; Satomi Tsuji; Hideo Ohira; Itsuko Sato; Mari Yamamoto; Hitomi Kohsaka; Seiji Kawano; Shizuya Yamashita; Yuichi Ishikawa; Yoshio Fujioka
Journal:  Lipids Health Dis       Date:  2012-10-31       Impact factor: 3.876

7.  Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association.

Authors:  Akihiro Shimada; Hideki Kimura; Koji Oida; Hideo Kanehara; Yukihiro Bando; Shinobu Sakamoto; Takanobu Wakasugi; Takashi Saga; Yasuki Ito; Kazuko Kamiyama; Daisuke Mikami; Masayuki Iwano; Tsutomu Hirano; Haruyoshi Yoshida
Journal:  Lipids Health Dis       Date:  2016-03-17       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.